A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle



Status:Completed
Conditions:Allergy, Ocular
Therapuetic Areas:Ophthalmology, Otolaryngology
Healthy:No
Age Range:10 - Any
Updated:11/11/2017
Start Date:June 2013
End Date:October 2013

Use our guide to learn which trials are right for you!

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Evaluation of the Onset and Duration of Action of AC-170 0.24% Ophthalmic Solution (Formula AFH-002) Compared to Vehicle (Formula AFH-001) in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

The purpose of this study is to evaluate the onset and duration of action of AC-170 0.24%
compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in
the conjunctival allergen challenge (CAC) model.


Inclusion Criteria:

- positive bilateral conjunctival allergen challenge (CAC) reaction

Exclusion Criteria:

- known contraindications or sensitivities to the study medication or its components

- any ocular condition that, in the opinion of the investigator, could affect the
subjects safety trial parameters

- use of disallowed medication during the period indicated prior to the enrollment or
during the study
We found this trial at
1
site
Andover, Massachusetts 01810
?
mi
from
Andover, MA
Click here to add this to my saved trials